FilingReader Intelligence
Baiyunshan announces 0.40 yuan dividend amid governance restructuring
August 15, 2025 at 03:30 PM UTC•By FilingReader AI
Guangzhou Baiyunshan Pharmaceutical Holdings announced a 0.40 yuan cash dividend per share for 2025, totaling 650 million yuan. Semi-annual revenue rose 1.93% to 41.8 billion yuan.
The company proposed removing its supervisory board and transferring functions to an audit committee as part of governance restructuring.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 2025 interim profit distribution plan announcementAugust 15, 2025 at 08:00 AM UTC
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 2025 half-yearly report summaryAugust 15, 2025 at 08:00 AM UTC
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited announcement regarding the by-election of directorsAugust 15, 2025 at 08:00 AM UTC
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited: announcement regarding the revision of relevant clauses in the articles of association, rules of procedure for the general meeting of shareholders, and rules of procedure for the board of directors, and the abolishment of the supervisory boardAugust 15, 2025 at 08:00 AM UTC
Special report by Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited on the deposit and actual use of raised funds for the first half of 2025August 15, 2025 at 08:00 AM UTC
SSE:600332•Shanghai Stock Exchange
News Alerts
Get instant email alerts when Guangzhou Baiyunshan Pharmaceutical Holdings publishes news
Free account required • Unsubscribe anytime